Want to create an interactive transcript for this episode?
Podcast: Sweat Capital
Episode: #88 Andrew Wilks: From The $3bn Sale of Momelotinib To Establishing A Leading Australian VC Fund - SYNthesis BioVentures (Biotech Entrepreneur)